Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

Testing for inherited susceptibility to breast cancer: a survey of informed consent forms for BRCA1 and BRCA2 mutation testing.

Durfy SJ, Buchanan TE, Burke W.

Am J Med Genet. 1998 Jan 6;75(1):82-7.

PMID:
9450863
[PubMed - indexed for MEDLINE]
2.

Informed consent for BRCA1 and BRCA2 testing: what clinicians should know about the process and content.

Miesfeldt S, Jones SM, Cohn WF.

J Am Med Womens Assoc. 2000 Fall;55(5):275-9.

PMID:
11070646
[PubMed - indexed for MEDLINE]
3.

Genetic counseling for BRCA1/BRCA2 testing.

Schneider KA.

Genet Test. 1997;1(2):91-8.

PMID:
10464632
[PubMed - indexed for MEDLINE]
4.

Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.

Schwartz MD, Benkendorf J, Lerman C, Isaacs C, Ryan-Robertson A, Johnson L.

Cancer. 2001 Aug 15;92(4):932-40.

PMID:
11550168
[PubMed - indexed for MEDLINE]
5.

Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.

Bluman LG, Rimer BK, Regan Sterba K, Lancaster J, Clark S, Borstelmann N, Iglehart JD, Winer EP.

Psychooncology. 2003 Jul-Aug;12(5):410-27.

PMID:
12833555
[PubMed - indexed for MEDLINE]
6.

Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.

Phillips KA, Warner E, Meschino WS, Hunter J, Abdolell M, Glendon G, Andrulis IL, Goodwin PJ.

Clin Genet. 2000 May;57(5):376-83.

PMID:
10852372
[PubMed - indexed for MEDLINE]
7.

Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.

Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, Chart P, Warner E.

CMAJ. 2001 Apr 3;164(7):1005-9.

PMID:
11314429
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Informed consent documents for BRCA1 and BRCA2 screening: how large is the readability gap?

Gribble JN.

Patient Educ Couns. 1999 Nov;38(3):175-83.

PMID:
10865683
[PubMed - indexed for MEDLINE]
9.

[BRCA1 and BRCA2: mutations and other genetic changes--practical relevance].

Scherneck S, Hofmann W.

Chirurg. 1999 Apr;70(4):373-9. Review. German.

PMID:
10354832
[PubMed - indexed for MEDLINE]
10.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
[PubMed - indexed for MEDLINE]
11.

Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.

Tercyak KP, Peshkin BN, Streisand R, Lerman C.

Psychooncology. 2001 Jul-Aug;10(4):336-46.

PMID:
11462232
[PubMed - indexed for MEDLINE]
12.

Factors associated with decisions about clinical BRCA1/2 testing.

Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1251-4.

PMID:
11097234
[PubMed - indexed for MEDLINE]
Free Article
13.

An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.

Lynch HT, Watson P, Tinley S, Snyder C, Durham C, Lynch J, Kirnarsky Y, Serova O, Lenoir G, Lerman C, Narod SA.

Cancer Genet Cytogenet. 1999 Mar;109(2):91-8.

PMID:
10087939
[PubMed - indexed for MEDLINE]
14.

Genetic susceptibility for breast cancer--risk assessment and counseling.

Ang P, Garber JE.

Semin Oncol. 2001 Aug;28(4):419-33. Review.

PMID:
11498834
[PubMed - indexed for MEDLINE]
15.

Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.

Essioux L, Girodet C, Sinilnikova O, Pagès S, Eisinger F, de Résende S, Maugard C, Lanoë D, Longy M, Bignon YJ, Sobol H, Bonaïti-Pellié C, Stoppa-Lyonnet D.

Am J Med Genet. 1998 Sep 23;79(3):175-83.

PMID:
9788557
[PubMed - indexed for MEDLINE]
16.

BRCA1/2 testing: complex themes in result interpretation.

Peshkin BN, DeMarco TA, Brogan BM, Lerman C, Isaacs C.

J Clin Oncol. 2001 May 1;19(9):2555-65. Review.

PMID:
11331335
[PubMed - indexed for MEDLINE]
17.

Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.

DiCastro M, Frydman M, Friedman I, Shiri-Sverdlov R, Papa MZ, Goldman B, Friedman E.

Am J Med Genet. 2002 Aug 1;111(2):147-51.

PMID:
12210341
[PubMed - indexed for MEDLINE]
18.

Informed consent for BRCA1 and BRCA2 testing.

Rimer BK, Sugarman J, Winer E, Bluman LG, Lerman C.

Breast Dis. 1998 Apr;10(1-2):99-114. Review.

PMID:
15687553
[PubMed - indexed for MEDLINE]
19.

Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations.

Ganguly A, Leahy K, Marshall AM, Dhulipala R, Godmilow L, Ganguly T.

Genet Test. 1997;1(2):85-90.

PMID:
10464631
[PubMed - indexed for MEDLINE]
20.

Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.

Lodder L, Frets PG, Trijsburg RW, Tibben A, Meijers-Heijboer EJ, Duivenvoorden HJ, Wagner A, van Der Meer CA, Devilee P, Cornelisse CJ, Niermeijer MF.

Eur J Hum Genet. 2001 Jul;9(7):492-500.

PMID:
11464240
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk